We use AI to unlock the immune system’s deep intelligence, enabling us to diagnose hard-to-detect diseases and develop new, targeted therapies for conditions that have long been underserved.

Our platform 

MyImmune’s AI-powered platform leverages adaptive immune networks to decode the immune system, transforming biological data into actionable insights that accelerate diagnostics and therapeutic discovery.

Our mission

Driven by a passion for innovation, MyImmune’s team works at the intersection of AI and immunology to develop advanced diagnostics and therapies that improve patient care.

Partnerships

Partner with MyImmune to unlock the full potential of the immune system for earlier disease detection, advanced therapeutic discovery, and deeper patient immune profiling

Our Science

“MyImmune’s approach to clustering BCR and TCR repertoire data, developed in Daron Standley’s lab at Osaka University, opens up new avenues for biomedical research.

Disease Detection

Leveraging adaptive immune receptor paratope networks, MyImmune’s platform can achieve highly accurate detection of cancer, autoimmune, and infectious diseases, while uncovering a reservoir of therapeutic immune cells in healthy individuals, opening new possibilities for precision diagnostics and treatment.

Antibody Clustering

Using a novel clustering method based on CDR sequences, MyImmune’s platform successfully identifies antigen-specific and neutralizing antibodies, offering a powerful tool for MyImmune to accelerate the discovery of therapeutic antibodies for diseases like cancer and autoimmune disorders.

Team

Florian Hauer, PhD

Founder and CEO

Prof Daron Standley, PhD

Founder and Chief Scientific Advisor

Ayan Sengupta

Founder and CTO

Debottam Upadhyaya

Lead Fullstack Engineer

Mara Anais Llamas Covarrubias, PhD

Scientist

Guy Cavet, PhD

Board of Directors

Maximilian Schmid, MD

Advisor

Get in touch to learn more!

Leave a message

ABOUT US

Imprint

Terms and Conditions

Privacy

FOLLOW US